» Articles » PMID: 31015135

Inverse Radiotherapy Planning Based on Bioeffect Modelling for Locally Advanced Left-sided Breast Cancer

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2019 Apr 25
PMID 31015135
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Treatment planning of radiotherapy (RT) for left-sided breast cancer is a challenging case. Several competing concerns are incorporated at present through protocol-defined dose-volume constraints, e.g. cardiac exposure and target coverage. Such constraints are limited by neglecting patient-specific risk factors (RFs). We propose an alternative RT planning method based solely on bioeffect models to minimize the estimated risks of breast cancer recurrence (BCR) and radiation-induced mortality endpoints considering patient-specific factors.

Methods And Materials: Thirty-nine patients with left-sided breast cancer treated with comprehensive post-lumpectomy loco-regional conformal RT were included. An in-house particle swarm optimization (PSO) engine was used to choose fields from a large set of predefined fields and optimize monitor units to minimize the total risk of BCR and mortality caused by radiation-induced ischaemic heart disease (IHD), secondary lung cancer (SLC) and secondary breast cancer (SBC). Risk models included patient age, smoking status and cardiac risk and were developed using published multi-institutional data.

Results: For the clinical plans the normal tissue complication probability, i.e. summed risk of IHD, SLC and SBC, was <3.7% and the risk of BCR was <6.1% for all patients. Median total decrease in mortality or recurrence achieved with individualized PSO plans was 0.4% (range, 0.06-2.0%)/0.5% (range, 0.11-2.2%) without/with risk factors.

Conclusions: Inverse RT plan optimization using bioeffect probability models allows individualization according to patient-specific risk factors. The modelled benefit when compared to clinical plans is, however, modest in most patients, demonstrating that current clinical plans are close to optimal. Larger gains may be achievable with morbidity endpoints rather than mortality.

Citing Articles

Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimization.

Polan D, Epelman M, Wu V, Sun Y, Varsta M, Owen D Med Phys. 2022; 49(10):6279-6292.

PMID: 35994026 PMC: 9826508. DOI: 10.1002/mp.15940.


Outcome-based multiobjective optimization of lymphoma radiation therapy plans.

Modiri A, Vogelius I, Rechner L, Nygard L, Bentzen S, Specht L Br J Radiol. 2021; 94(1127):20210303.

PMID: 34541859 PMC: 8553178. DOI: 10.1259/bjr.20210303.


Reduction of heart and lung normal tissue complication probability using automatic beam angle optimization and more generic optimization objectives for breast radiotherapy.

Bakx N, Bluemink H, Hagelaar E, van der Leer J, Van der Sangen M, Theuws J Phys Imaging Radiat Oncol. 2021; 18:48-50.

PMID: 34258407 PMC: 8254193. DOI: 10.1016/j.phro.2021.04.002.

References
1.
Stick L, Yu J, Maraldo M, Aznar M, Pedersen A, Bentzen S . Joint Estimation of Cardiac Toxicity and Recurrence Risks After Comprehensive Nodal Photon Versus Proton Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2017; 97(4):754-761. PMC: 5625081. DOI: 10.1016/j.ijrobp.2016.12.008. View

2.
Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

3.
Vogelius I, Bentzen S . A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol. 2012; 51(8):975-83. PMC: 3557496. DOI: 10.3109/0284186X.2012.718093. View

4.
Thorsen L, Offersen B, Dano H, Berg M, Jensen I, Pedersen A . DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J Clin Oncol. 2015; 34(4):314-20. DOI: 10.1200/JCO.2015.63.6456. View

5.
Damkjaer S, Aznar M, Pedersen A, Vogelius I, Peter Bangsgaard J, Josipovic M . Reduced lung dose and improved inspiration level reproducibility in visually guided DIBH compared to audio coached EIG radiotherapy for breast cancer patients. Acta Oncol. 2013; 52(7):1458-63. DOI: 10.3109/0284186X.2013.813073. View